🇺🇸 FDA
Patent

US 7622444

Methods for using OX-40 ligand to enhance an antigen specific immune response

granted A61KA61K2039/55516A61K38/177

Quick answer

US patent 7622444 (Methods for using OX-40 ligand to enhance an antigen specific immune response) held by Sisters of Providence in Oregon expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sisters of Providence in Oregon
Grant date
Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/55516, A61K38/177, A61K39/0005, A61K39/39